IRIN Examines Global Trend In Collaborative Health Research

“Dwindling money for research and development (R&D) and waning donor patience have forced global health players to change how they innovate new products and processes,” IRIN reports. “A growing trend in collaborative health research is creating potentially life-saving global partnerships between pharmaceutical companies, academic researchers, disease advocates, and even the general public, who are drawn into the world of science through ‘crowd-sourcing,'” the news service writes, adding, “Partners — who might once have been competitors — are increasingly sharing expertise, intellectual property and financing.” IRIN highlights a number of initiatives and product-development partnerships (PDPs), including the “Re:Search project, a partnership launched in 2011 between BIO Ventures and the World Intellectual Property Organization (WIPO), which … calls for a more global interpretation of intellectual property to spur health innovation and development, and the collaboration of biotechnology firms, pharmaceutical companies and academia” (7/30).   

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.